TransMedics Group (TMDX) Gets Buy Rating From Needham Analyst, Sees ‘Bending the Organ Transplant Curve’

Needham analyst initiated coverage on TransMedics Group (TMDX), a medical technology company revolutionizing organ transplantation with its Organ Care System (OCS). The analyst sees significant growth potential in the underpenetrated organ transplant market, driven by the company’s National OCS Program (NOP) and innovative OCS technology. The analyst predicts TransMedics will become profitable in 2024 and sees rapid improvement in operating margin, EPS, and cash flow in 2025-2026.

Illegal Organ Transplant Racket Busted in Delhi, NOTTO Seeks Report from UP Government

The National Organ & Tissue Transplant Organization (NOTTO) has demanded an urgent report from the Uttar Pradesh government after an illegal organ transplant racket was uncovered at Indraprastha Apollo Hospital in Delhi, linked to Yatharth Hospital in Noida. The racket involved a senior kidney transplant surgeon who allegedly performed surgeries on Bangladeshi patients without proper authorization. The doctor has been arrested along with six others, and the investigation is ongoing.

India Tightens Regulations for Foreign Organ Transplants Amid Rise in Commercial Dealings

The Indian government is taking steps to ensure ethical organ transplants for foreign nationals. The Ministry of Health has asked the Ministries of Home and External Affairs to raise awareness about legal requirements for organ transplants, amid concerns over commercial dealings. This includes displaying information at airports and on immigration websites, highlighting the need for donor-recipient relationship verification and the prohibition of commercial organ trade.

Scroll to Top